Global upscaling Target OEMs and biotech startups seeking cost-effective scale-up of precision fermentation for proteins and other molecules across food, nutrition, agriculture, biomaterials, and biomining to bridge the valley of death from lab to market.

Pilot plant expansion Leverage their recent investment in a pilot plant facility to offer pilot-scale production services, process optimization, and technology transfer to partners looking to de-risk scale-up before full commercial manufacturing.

Strategic partnerships Engage with companies like AMSilk for collaboration on spider silk–based proteins and other advanced materials, presenting opportunities for joint development, co-funded projects, and accelerated go-to-market timelines.

End-to-end support Position 21st.BIO as a one-stop solution for technical assessment, strain development, production upscaling, regulatory services, and tech transfer to shorten customer time-to-market and reduce operational risk.

Global reach with local access Highlight dual locations in Copenhagen and Davis, enabling regional support, faster customer onboarding in Europe and North America, and potential localized manufacturing or tech transfer partnerships to meet diverse regulatory and market needs.